Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Gout and Hyperuricemia”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Large-scale testing (Phase 3)Study completedNCT05586971
What this trial is testing

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

Who this might be right for
GoutHyperuricemiaGout Flare+1 more
LG Chem 2,202
Testing effectiveness (Phase 2)Looking for participantsNCT07362355
What this trial is testing

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Who this might be right for
Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 340
Testing effectiveness (Phase 2)UnknownNCT05513976
What this trial is testing

Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Who this might be right for
Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 129
Testing effectiveness (Phase 2)Study completedNCT01712204
What this trial is testing

A Proof-of-Concept Study of AC-201 to Prevent Gout Flares

Who this might be right for
Gout Flares
TWi Biotechnology, Inc. 82
Large-scale testing (Phase 3)Looking for participantsNCT05658575
What this trial is testing

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Who this might be right for
Acute Gout FlareGout AttackGout Flare+4 more
Olatec Therapeutics LLC 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05690204
What this trial is testing

Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Who this might be right for
Gout
Shanton Pharma Pte. Ltd. 87
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07498647
What this trial is testing

Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Who this might be right for
Gout and Hyperuricemia
BioRay Pharmaceutical Co., Ltd. 160
Testing effectiveness (Phase 2)Ended earlyNCT04067492
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack

Who this might be right for
Gout Attack
R-Pharm 47
Not applicableNot Yet RecruitingNCT07061587
What this trial is testing

Developing A Gout Action Plan in Primary Care Setting in Singapore

Who this might be right for
Gout; HyperuricemiaGout FlareGout Chronic
SingHealth Polyclinics 72
Not applicableUnknownNCT05522504
What this trial is testing

Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

Who this might be right for
Gout FlareIntercritical GoutAdvanced Gout+1 more
Ai Peng 600
Early research (Phase 1)UnknownNCT04586803
What this trial is testing

Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers

Who this might be right for
Primary GoutHyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)UnknownNCT05347498
What this trial is testing

A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults

Who this might be right for
Primary Gout With Hyperuricemia in Adults
Jiangsu HengRui Medicine Co., Ltd. 90
Large-scale testing (Phase 3)Active Not RecruitingNCT06603142
What this trial is testing

Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia

Who this might be right for
Primary GoutHyperuricemia
Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd 636
Large-scale testing (Phase 3)Study completedNCT05586958
What this trial is testing

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

Who this might be right for
GoutHyperuricemiaGout Flare+1 more
LG Chem 354